Skip to main content
Kent Academic Repository

Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus.

Hoever, Gerold, Baltina, Lidia, Michaelis, Martin, Kondratenko, Rimma, Baltina, Lia, Tolstikov, Genrich A, Doerr, Hans Wilhelm, Cinatl, Jindrich (2005) Antiviral activity of glycyrrhizic acid derivatives against SARS-coronavirus. Journal of Medicinal Chemistry, 48 (4). pp. 1256-9. ISSN 0022-2623. (doi:10.1021/jm0493008) (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided) (KAR id:34111)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided.
Official URL:
https://doi.org/10.1021/jm0493008

Abstract

Glycyrrhizin (GL) was shown to inhibit SARS-coronavirus (SARS-CoV) replication in vitro. Here the anti-SARS-CoV activity of 15 GL derivatives was tested. The introduction of 2-acetamido-beta-d-glucopyranosylamine into the glycoside chain of GL resulted in 10-fold increased anti-SARS-CoV activity compared to GL. Amides of GL and conjugates of GL with two amino acid residues and a free 30-COOH function presented up to 70-fold increased activity against SARS-CoV but also increased cytotoxicity resulting in decreased selectivity index.

Item Type: Article
DOI/Identification number: 10.1021/jm0493008
Subjects: R Medicine > RM Therapeutics. Pharmacology
Divisions: Divisions > Division of Natural Sciences > Biosciences
Depositing User: Martin Michaelis
Date Deposited: 05 Jun 2013 20:32 UTC
Last Modified: 09 Mar 2023 11:32 UTC
Resource URI: https://kar.kent.ac.uk/id/eprint/34111 (The current URI for this page, for reference purposes)

University of Kent Author Information

  • Depositors only (login required):

Total unique views for this document in KAR since July 2020. For more details click on the image.